Stock Market News10 hours Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 Seeking Alpha
X13 hours Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? Zacks
X15 hours Ionis Pharmaceuticals: Promising Growth From Tryngolza Approval Seeking Alpha
X16 hours Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks
X3 days Is Recursion Pharmaceuticals Stock a Millionaire Maker? Yahoo Finance
X3 days Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein Yahoo Finance
X3 days Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily
X3 days Ironwood Pharmaceuticals shares surge on competitor’s woes Investing.com
X3 days Rhythm Pharmaceuticals’ Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential Yahoo Finance
X3 days Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity Seeking Alpha
X3 days VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo Zacks
X4 days Cramer’s Mad Dash: Vertex Pharmaceuticals YouTube
X4 days Ionis Gets FDA Approval for Rare Disease Drug Tryngolza Zacks
X5 days Cramer’s Stop Trading: Vertex Pharmaceuticals YouTube
X5 days Vertex Non-Opioid Drug Doesn’t Best Placebo In Back Pain Study. The Stock Is Plunging. Investor's Business Daily
X5 days Corvus Pharmaceuticals: Not Just A One-Hit Wonder In ITK Inhibitor Targeting Seeking Alpha
X6 days REGN’s Eylea HD Shows Non-Inferiority to Eylea in Eye Disease Study Zacks
X6 days Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks
X6 days Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X6 days SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study Zacks
X6 days Corvus Pharmaceuticals stock rebounds on positive trial results Investing.com
X6 days Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC
X6 days NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks
X7 days 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks
X7 days Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know Zacks
X1 week Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today Zacks
X1 week BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks
X1 week Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison’s Top 2 Picks Seeking Alpha
X1 week Inovio Pharmaceuticals: The Dangerous Allure Of A Falling Knife Seeking Alpha
X2 weeks Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks
X2 weeks Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue? Zacks
X2 weeks Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report? Zacks
X2 weeks Phathom Pharmaceuticals: The Large Drop Is, Well, Unfathomable Seeking Alpha
X2 weeks Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is Low Seeking Alpha
X2 weeks Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy Seeking Alpha
X2 weeks How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91% Zacks
X2 weeks Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks
X2 weeks Tarsus Pharmaceuticals: Early Rollout Exceeding Expectations Seeking Alpha
X2 weeks Here’s Why Agios Stock Plummeted More Than 20% on Monday Zacks
X2 weeks Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options Zacks
X2 weeks Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? Zacks
X2 weeks BioCryst Pharmaceuticals: Seasoned Blockbuster Makes It A Buy Seeking Alpha
X2 weeks Agios Crashes 21% After A Surprise Side Effect Hammered Its ‘Very Safe’ Drug Investor's Business Daily
X2 weeks Catalyst Pharmaceuticals: Agamree Is Its Key To A Sustainable Future Seeking Alpha
X2 weeks Rhythm Pharmaceuticals: A Key Year Ahead Seeking Alpha
X2 weeks Ionis Pharmaceuticals (IONS) Down 4.5% Since Last Earnings Report: Can It Rebound? Zacks
X2 weeks Acadia (ACAD) Down 2.9% Since Last Earnings Report: Can It Rebound? Zacks
X3 weeks Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand Zacks
X3 weeks Down -54.05% in 4 Weeks, Here’s Why Phathom Pharmaceuticals (PHAT) Looks Ripe for a Turnaround Zacks
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.